JP2001519808A - ポリ芳香族抗菌組成物 - Google Patents

ポリ芳香族抗菌組成物

Info

Publication number
JP2001519808A
JP2001519808A JP54282798A JP54282798A JP2001519808A JP 2001519808 A JP2001519808 A JP 2001519808A JP 54282798 A JP54282798 A JP 54282798A JP 54282798 A JP54282798 A JP 54282798A JP 2001519808 A JP2001519808 A JP 2001519808A
Authority
JP
Japan
Prior art keywords
phenylene
bis
oxydi
phenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP54282798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001519808A5 (cg-RX-API-DMAC10.html
Inventor
バーバチン,マイケル・アール
ホーマ,フレッド・エル
モンヘ,アントニオ
サンティアゴ,エステバン
マルティネス−イルホ,フアン・ホタ
フォント,マリア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of JP2001519808A publication Critical patent/JP2001519808A/ja
Publication of JP2001519808A5 publication Critical patent/JP2001519808A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/18—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
JP54282798A 1997-04-10 1998-04-01 ポリ芳香族抗菌組成物 Withdrawn JP2001519808A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4323297P 1997-04-10 1997-04-10
US60/043,232 1997-04-10
PCT/US1998/006152 WO1998045259A2 (en) 1997-04-10 1998-04-01 Polyaromatic antiviral compositions

Publications (2)

Publication Number Publication Date
JP2001519808A true JP2001519808A (ja) 2001-10-23
JP2001519808A5 JP2001519808A5 (cg-RX-API-DMAC10.html) 2005-11-24

Family

ID=21926169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54282798A Withdrawn JP2001519808A (ja) 1997-04-10 1998-04-01 ポリ芳香族抗菌組成物

Country Status (9)

Country Link
US (2) US5958983A (cg-RX-API-DMAC10.html)
EP (1) EP0973735B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001519808A (cg-RX-API-DMAC10.html)
AT (2) ATE298741T1 (cg-RX-API-DMAC10.html)
AU (1) AU6783698A (cg-RX-API-DMAC10.html)
DE (2) DE69811062T2 (cg-RX-API-DMAC10.html)
DK (1) DK0973735T3 (cg-RX-API-DMAC10.html)
ES (2) ES2243370T3 (cg-RX-API-DMAC10.html)
WO (1) WO1998045259A2 (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505086A (ja) * 2003-09-11 2007-03-08 テイボテク・フアーマシユーチカルズ・リミテツド Hivウイルス侵入阻害剤
JP2007523868A (ja) * 2003-07-10 2007-08-23 アキリオン ファーマシューティカルズ,インコーポレーテッド ウイルス複製の阻害薬として有用な置換アリールチオウレア誘導体類
JP2010215533A (ja) * 2009-03-13 2010-09-30 Kagoshima Univ ジフェニルメタン誘導体を有効成分とする抗ウイルス剤

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US6262090B1 (en) * 1998-12-09 2001-07-17 American Home Products Corporation Aminopyridine-containing thiourea inhibitors of herpes viruses
US6166028A (en) 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
BR9915993A (pt) * 1998-12-09 2001-09-04 American Home Prod Composto, composição farmacêutica, processo para inibir a replicação de um vìrus herpes, e, processo para tratar um paciente sofrendo de uma infecção de vìrus herpes
US6201013B1 (en) 1998-12-09 2001-03-13 American Home Products Corporation Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
US6335350B1 (en) 1998-12-09 2002-01-01 American Home Products Corporation Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
CN1367785A (zh) * 1998-12-09 2002-09-04 美国家庭用品有限公司 含取代的苯二胺基团的含杂环羧酰胺的疱疹病毒硫脲抑制剂
ID30158A (id) * 1998-12-09 2001-11-08 American Home Prod Thiourea yang mengandung heterosiklik karboksamida, pencegah-pencegah virus-virus herpes yang mengandung gugus fenilenadiamina
US6197803B1 (en) 1998-12-09 2001-03-06 American Home Products Corporation Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
CN1333750A (zh) * 1998-12-09 2002-01-30 美国家庭用品有限公司 含乙酰胺和取代的乙酰胺的疱疹病毒硫脲抑制剂
WO2000034269A1 (en) * 1998-12-09 2000-06-15 American Home Products Corporation Thiourea inhibitors of herpes viruses
EP1140840B1 (en) * 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (en) * 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2001017953A1 (en) * 1999-09-08 2001-03-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US7371763B2 (en) 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
DK1478358T3 (da) 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
ATE529406T1 (de) 2002-02-11 2011-11-15 Bayer Healthcare Llc Aryl-harnstoffe als kinase inhibitoren
DE10217518A1 (de) * 2002-04-19 2003-11-06 Bayer Ag Lactone
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
AU2004234066B2 (en) 2003-04-30 2008-02-21 Novartis Ag Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
EP1636585B2 (en) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
EP1651595A2 (en) 2003-05-30 2006-05-03 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
PL1663978T3 (pl) 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
EP3837275A4 (en) 2018-06-29 2022-07-13 Fred Hutchinson Cancer Center CELL STORED BARCODED DEEP MUTATION SCANNING LIBRARIES AND THEIR USES
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56108759A (en) * 1980-01-29 1981-08-28 Mitsui Toatsu Chem Inc Novel bisphenol compound and its preparation
BR8108994A (pt) * 1981-03-30 1983-03-01 Ciba Geigy Ag Fenoxifenilisotioureias fenoxifeniltioureias como produtos intermediarios sua preparacao e emprego no combate de pragas
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
JPH02237922A (ja) * 1989-01-24 1990-09-20 Green Cross Corp:The 抗ウィルス剤
NZ240313A (en) * 1990-10-22 1994-04-27 Res Corp Technologies Inc Anti-retrovirus compositions containing aryl and heteroaryl derivatives
EP0498095B1 (en) * 1991-02-05 1995-01-04 Merrell Dow Pharmaceuticals Inc. Sulfonic stilbene derivatives in the treatment of viral diseases
US5569643A (en) * 1991-03-07 1996-10-29 Nippon Oil Co., Ltd. Grease composition for constant velocity joint
NZ243180A (en) * 1991-06-19 1995-08-28 Schering Corp Aromatic ether derivatives and antiviral compositions thereof
EP0571083B1 (en) * 1992-05-18 1997-06-18 Kao Corporation Developer additive, toner and developer composition
JP3603315B2 (ja) * 1993-02-19 2004-12-22 日本製紙株式会社 近赤外線吸収剤およびそれを含有した熱線遮蔽材
JP3509082B2 (ja) * 1994-06-23 2004-03-22 日本製紙株式会社 感熱記録体
DE69613410T2 (de) * 1995-01-31 2002-05-02 Mitsubishi Chemical Corp., Tokio/Tokyo Ladungssteuerungsmittel für die Entwicklung elektrostatischer Bilder, und Toner und ladungserzeugendes Material die es enthalten

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007523868A (ja) * 2003-07-10 2007-08-23 アキリオン ファーマシューティカルズ,インコーポレーテッド ウイルス複製の阻害薬として有用な置換アリールチオウレア誘導体類
JP2007505086A (ja) * 2003-09-11 2007-03-08 テイボテク・フアーマシユーチカルズ・リミテツド Hivウイルス侵入阻害剤
JP2010215533A (ja) * 2009-03-13 2010-09-30 Kagoshima Univ ジフェニルメタン誘導体を有効成分とする抗ウイルス剤

Also Published As

Publication number Publication date
US6147116A (en) 2000-11-14
EP0973735B1 (en) 2003-01-29
ES2243370T3 (es) 2005-12-01
EP0973735A2 (en) 2000-01-26
US5958983A (en) 1999-09-28
WO1998045259A2 (en) 1998-10-15
ES2191292T3 (es) 2003-09-01
DE69830751T2 (de) 2006-05-18
ATE231839T1 (de) 2003-02-15
DE69811062T2 (de) 2003-07-17
ATE298741T1 (de) 2005-07-15
DK0973735T3 (da) 2003-06-23
WO1998045259A3 (en) 1999-02-25
AU6783698A (en) 1998-10-30
DE69830751D1 (de) 2005-08-04
DE69811062D1 (de) 2003-03-06

Similar Documents

Publication Publication Date Title
EP0973735B1 (en) Polyaromatic antiviral compositions
AU603012B2 (en) N-substituted derivatives of 1-desoxynojirimycin 1- desoxymannojirimycin, processes for their preparation and their use in medicaments
EP0672031B1 (en) Catechol diethers as selective pde iv inhibitors
ES2544511T3 (es) Compuestos de aril-fenil-sulfonamido-cicloalquilo y su uso
RU2330851C2 (ru) ПИРИДО[2,3-b]ПИРАЗИНОВЫЕ ПРОИЗВОДНЫЕ, ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ ИЛИ НАРУШЕНИЯ, КОТОРЫЕ ОБУСЛОВЛЕНЫ НЕПРАВИЛЬНО НАПРАВЛЕННЫМИ ПРОЦЕССАМИ КЛЕТОЧНОЙ СИГНАЛЬНОЙ ТРАНСДУКЦИИ, СПОСОБ ПОЛУЧЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА
NO20041112L (no) 1-Substituerte-1-aminometyl-cykloalkanderivater (=gabapentinanaloger), deres fremstilling og deres anvendelse ved behandiing av neurologiske lidelser
CZ398291A3 (en) 4-amino-3-carbonylquinoline derivatives, and pharmaceutical preparations in which they are comprised
ZA200509241B (en) New benzimidazole derivatives
CN1500089A (zh) 作为辣椒素受体拮抗剂用于治疗疼痛的稠合吡啶衍生物
CZ46799A3 (cs) IL-8 receptor antagonistů
MX2009001791A (es) Arilsulfonamidas con efecto analgesico.
MX2008014108A (es) Moduladores bencimidazolicos de receptor de capsaicina (vr1).
CN109836477B (zh) 含有苯并噻二嗪-3-酮1,1-二氧化物的苯丙氨酸衍生物及其制备方法与应用
KR20070007759A (ko) 바이러스 복제 억제제로서 유용한 치환된 아릴티오우레아유도체
ES2292462T3 (es) Agentes abridores de los canales del potasio.
WO2020172932A1 (zh) 苯胺类wdr5蛋白-蛋白相互作用抑制剂及其制法和用途
WO2002036588A2 (en) Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
BRPI0712483A2 (pt) sais de ácido clorìdrico de 6-metóxi-8-[4-1-(5-flúor)-quinolin-8-il-piperidin-4-il)-pip erazin-1-il]-quinolina
PL150841B1 (en) Purine compounds.
RU2648242C2 (ru) Производное имидазопиридина, используемое для лечения сахарного диабета
CN106543077B (zh) N,n’-双取代芳基硫脲衍生物及其合成方法和应用
ES2311594T3 (es) Agentes que pueden abrir los canales del potasio.
EP1245561B1 (en) N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
JP2023503091A (ja) Trpv4受容体リガンド
EP1148048B1 (en) Polyaromatic compounds for treating herpes viral infections

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050401

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050401

A72 Notification of change in name of applicant

Free format text: JAPANESE INTERMEDIATE CODE: A721

Effective date: 20051212

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20051212